» Articles » PMID: 24885975

Synaptosomal-associated Protein 25 (Snap-25) Gene Polymorphism Frequency in Fibromyalgia Syndrome and Relationship with Clinical Symptoms

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2014 Jun 3
PMID 24885975
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: SNAP-25 protein is contributory to plasma membrane and synaptic vesicle fusions that are critical points in neurotransmission. SNAP-25 gene is associated with behavioral symptoms, personality and psychological disorders. In addition, SNAP-25 protein can be related to different neurotransmitter functions due to its association with vesicle membrane transition and fusion. This is important because neurologic, cognitive, and psychologic disorders in fibromyalgia syndrome (FMS) can be related to this function. This relationship may be enlightening for etiopathogenesis of FMS and treatment approaches. We aimed to study a SNAP-25 gene polymorphism, which is related to many psychiatric diseases, and FMS association in this prospective study.

Methods: We included 71 patients who were diagnosed according to new criteria and 57 matched healthy women in this study. Both groups were evaluated regarding age, height, weight, BMI, education level, marital and occupational status. A new diagnosis of FMS was made from criteria scoring, SF-36, Beck depression scale, and VAS that were applied to the patient group. SNAP-25 gene polymorphism and disease activity score correlations were compared.

Results: Mean age was 38±5,196 and 38.12±4.939 in patient and control groups, respectively (p=0.542). No significant difference was found between groups regarding age, height, weight, BMI, education level, marital or occupational status (p > 0.05). Ddel T/C genotype was significantly higher in the patient group (p = 0.009). MnlI gene polymorphism did not show a correlation with any score whereas a significant correlation was found between Ddel T/C genotype and Beck depression scale and VAS score (p < 0.05).

Conclusion: FMS etiopathogenesis is not clearly known. Numerous neurologic, cognitive and psychological disorders were found during studies looking at cause. Our study showed increased SNAP-25 Ddel T/C genotype in FMS patients compared to the control group, which is related to behavioral symptoms, personality and psychological disorders in FMS patients.

Citing Articles

A Comprehensive Review of the Genetic and Epigenetic Contributions to the Development of Fibromyalgia.

Ovrom E, Mostert K, Khakhkhar S, McKee D, Yang P, Her Y Biomedicines. 2023; 11(4).

PMID: 37189737 PMC: 10135661. DOI: 10.3390/biomedicines11041119.


Topical Treatments and Their Molecular/Cellular Mechanisms in Patients with Peripheral Neuropathic Pain-Narrative Review.

Kocot-Kepska M, Zajaczkowska R, Mika J, Kopsky D, Wordliczek J, Dobrogowski J Pharmaceutics. 2021; 13(4).

PMID: 33810493 PMC: 8067282. DOI: 10.3390/pharmaceutics13040450.


Peripheral Mechanisms of Neuropathic Pain-the Role of Neuronal and Non-Neuronal Interactions and Their Implications for Topical Treatment of Neuropathic Pain.

Kocot-Kepska M, Zajaczkowska R, Mika J, Wordliczek J, Dobrogowski J, Przeklasa-Muszynska A Pharmaceuticals (Basel). 2021; 14(2).

PMID: 33498496 PMC: 7909513. DOI: 10.3390/ph14020077.


Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.

Bodewes I, van der Spek P, Leon L, Wijkhuijs A, van Helden-Meeuwsen C, Tas L Front Immunol. 2019; 10:312.

PMID: 30863411 PMC: 6399420. DOI: 10.3389/fimmu.2019.00312.


Synaptosomal-associated protein 25 may be an intervention target for improving sensory and locomotor functions after spinal cord contusion.

Zhong Z, Xiang Y, Hu X, Wang Y, Zeng X, Wang X Neural Regen Res. 2017; 12(6):969-976.

PMID: 28761431 PMC: 5514873. DOI: 10.4103/1673-5374.208592.


References
1.
Malt E, Olafsson S, Aakvaag A, Lund A, Ursin H . Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J Affect Disord. 2003; 75(1):77-82. DOI: 10.1016/s0165-0327(02)00025-3. View

2.
Arnold L, Hudson J, Keck P, Auchenbach M, Javaras K, Hess E . Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006; 67(8):1219-25. DOI: 10.4088/jcp.v67n0807. View

3.
Anisman H, Merali Z . Cytokines, stress and depressive illness: brain-immune interactions. Ann Med. 2003; 35(1):2-11. DOI: 10.1080/07853890310004075. View

4.
Chakrabarty S, Zoorob R . Fibromyalgia. Am Fam Physician. 2007; 76(2):247-54. View

5.
Semiz U, Basoglu C, Oner O, Munir K, Ates A, Algul A . Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry. 2008; 42(5):405-13. PMC: 3166642. DOI: 10.1080/00048670801961099. View